Today is International Clinical Trials Day 2020. The day commemorates the day James Lind started his study to determine the cause of scurvy. By dividing 12 sailors into separate groups and testing the effect of providing different treatments to each group, Lind was able to provide evidence of the link between fruit and preventing scurvy. This is the first recorded controlled clinical trial and changed modern medicine. Around the world International Clinical Trials Day is celebrated to raise awareness of the importance of clinical trials and research in healthcare.
Today we hear from Christine Zahren Co-Founder and Director of White Coats Foundation about the importance of clinical trials and involving the patient in the protocol design, to ensure success from “lab bench to bedside”. She also references where information on clinical trials can be found, through government sites, healthcare professionals and also ClinTrial Refer where she works as business development manager.
#InternationalClinicalTrialsDay2020hashtag
#ICTD2020
#InternationalClinicalTrialsDay
#whitecoatsfoundationhashtag
#clinicaltrialshashtag
#CaptureEveryStory
-
Entering The New Health Frontier
A new parliamentary report ‘The New Frontier: Delivering better health for all Australians’ is recommending significant reforms to the health care system to ensure Australians have better and faster access to the wave of new medicines and technologies.
The bipartisan report makes 31 recommendations to reform Australia’s system for the regulation and reimbursement with the hope that patients will receive faster access to the latest medicines and technologies.
-
Improved treatment in advanced-stage Hodgkin lymphoma
A global clinical trial successfully reduced toxicity and side effects in advanced stage Hodgkin lymphoma patients by using a modified treatment regimen.
Australian Health Journal spoke with Professor Mark Hertzberg in his role in the ALLG HD10 Clinical Trial and as a former Chair of the Scientific Advisory Committee of the Australasian Leukaemia & Lymphoma Group (ALLG), an organisation involved in improving the treatments and lives of blood cancer patients.
-
Stroke care advances in translated research
New nurse-led protocols for stroke patients, based on ACU research, led by the Nursing Research Institute, have resulted in changes to policy, guidelines and clinical practice in Europe and Australia. The protocols were developed through the Quality in Acute Stroke Care (QASC) Trial (published in the Lancet, 2011) to manage fever, hyperglycaemia and swallowing (FeSS) post-stroke.
